Guarding their hearts: Gnosis by Lesaffre’s MK-7 fights leading cause of premature death in women

09 Jun 2023 — New research shows that women are at a greater risk of developing heart disease than previously thought. However, according to several company-driven clinical trials, supplementing with Gnosis by Lesaffre’s MenaQ7 vitamin K2 – on the market as MK-7 – can protect and support cardiovascular function and promote greater heart health in women. 

The company highlights that reproductive and menopause factors are linked to developing adverse conditions, noting that a recent observational study linked higher risks of cardiovascular diseases (CVD) in women to earlier first birth, a higher number of births and first menstruation at a younger age.